Bruker Reports Growth in Revenue, Profits; Expects Trends to Continue | GenomeWeb

NEW YORK, March 1 – Mass spectrometer maker Bruker Daltonics reported Thursday a 14.1 percent increase in fourth quarter revenues to $21.8 million, compared with $19.1 million in the year ago period, despite unfavorable foreign currency effects.

Top line growth before the currency effects increased 43 percent. As a percent of product revenues, life science systems revenue accounted for 69 percent, substance detection systems revenue accounted for 17 percent, and aftermarket revenues made up 14 percent in the last three months of 1999.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."